Paving the Way for eHealth Interoperability: The EURO-CAS Project Launches Today

The EURO-CAS project launched operations today to deliver the eHealth Conformity Assessment Scheme for Europe in 2018. This scheme will help European health systems assess the conformity of eHealth products and solutions with international standards, and will enhance vendors' visibility by offering public recognition of conformity of their products. This will advance eHealth interoperability, help advance the European Digital Single Market in the health and care domain, and facilitate the sharing of information for better and more person-centred healthcare.

Led by IHE-Europe, a recognised leader in eHealth standards, the EURO-CAS consortium consists of representatives and competence centres of key European regions and Member States, as well as experts and international associations. Together they will assess the interoperability requirements of European health systems and analyse the existing testing and certification schemes, before developing and testing a European conformity scheme in several regions, guided by an advisory board of additional experts and policymakers. The finalised EURO-CAS model will be presented in November 2018 to the public.

"Lack of interoperability is both a reason for, and a result of, the fragmentation of eHealth markets in Europe and the endurance of information silos," says Karima Bourquard, Director of interoperability at IHE Europe, and scientific coordinator of EURO-CAS. "The EURO-CAS conformity assessment scheme will provide a comprehensive framework, with flexibility to allow better sustainability and harmonisation at European, national and regional levels."

EURO-CAS will build on the findings and results of a series of EU-funded projects that have advanced eHealth interoperability within and between Member States in the last years, and will provide a scheme consistent with the Refined eHealth European Interoperability Framework endorsed by representatives of all 28 European Member States in 2015.

The EURO-CAS conformity assessment scheme for Europe will consist of models, processes and tools that will enable and strengthen the capability of test centres to assess eHealth product and solutions, not only in regard to international standards and interoperability requirements of European eHealth projects, but also in regard to national and regional eHealth requirements.

The EURO-CAS project is committed to transparency and openness, and invites interested parties to join and contribute. They can engage face to face with consortium members during EURO-CAS events, or offer comments and feedback to key deliverables that will be offered for public consultation.

For further information, please visit:
http://www.euro-cas.eu

About the EURO-CAS project

The European eHealth Interoperability Conformity Assessment Scheme for Europe (EURO-CAS) will between 2016 and 2018 develop the sustainable Conformity Assessment Scheme (CAS) for Europe, which will promote the adoption and take-up of interoperability testing of eHealth solutions against identified eHealth standards and profiles defined in the eHealth European Interoperability Framework (eEIF). The project is led by IHE Europe (BE) and coordinated by EIBIR (AT), and joined by fourteen national and regional government bodies, competence centres, and associations. The EURO-CAS project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 727028.

Most Popular Now

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...

Virtual Reality Environment for Teens ma…

Social media. The climate crisis. Political polarization. The tumult of a pandemic and online learning. Teens today are dealing with unprecedented stressors, and over the past decade their mental health...

AI Predicts Tumor-Killing Cells with Hig…

Using artificial intelligence, Ludwig Cancer Research scientists have developed a powerful predictive model for identifying the most potent cancer killing immune cells for use in cancer immunotherapies. Combined with additional algorithms...

Researchers Use Foundation Models to Dis…

Researchers at Mass General Brigham have harnessed the technology behind foundation models, which power tools like ChatGPT, to discover new cancer imaging biomarkers that could transform how patterns are identified...